An Multicentre Clinical Study to Evaluate the Usability and Safety of the Autoinjector and Pre-filled Syringe of SB4 in Subjects With Rheumatoid Arthritis

Inclusion Criteria: * Subjects are male or female aged 18-55 years at the time of signing the informed consent form. Exclusion Criteria: * Have been treated previously with monoclonal antibody agent including any tumour necrosis factor inhibitor except SB4.